{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:50:33Z","timestamp":1791607833143,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004343","name":"3M Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.imlet.2021.03.006","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T18:23:35Z","timestamp":1615573415000},"page":"31-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Effect of Perfluorooctanesulfonic acid (PFOS) on immune cell development and function in mice"],"prefix":"10.1016","volume":"233","author":[{"given":"Luisa","family":"Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amie","family":"Redko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Limper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Imbiakha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avery","family":"August","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.imlet.2021.03.006_bib0005","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ieam.258","article-title":"Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins","volume":"7","author":"Buck","year":"2011","journal-title":"Integr. Environ. Assess. Manag."},{"key":"10.1016\/j.imlet.2021.03.006_bib0010","series-title":"(Paris, Hazard Assessment of Perfluorooctane Sulfonate (PFOS) and Its Salts","first-page":"1","author":"F. OECD","year":"2002"},{"issue":"9","key":"10.1016\/j.imlet.2021.03.006_bib0015","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1289\/ehp.10009","article-title":"Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers","volume":"115","author":"Olsen","year":"2007","journal-title":"Environ. Health Perspect."},{"issue":"4","key":"10.1016\/j.imlet.2021.03.006_bib0020","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.reprotox.2011.07.002","article-title":"Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys","volume":"33","author":"Chang","year":"2012","journal-title":"Reprod. Toxicol."},{"issue":"1","key":"10.1016\/j.imlet.2021.03.006_bib0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/oemed-2017-104651","article-title":"Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water","volume":"75","author":"Li","year":"2018","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.imlet.2021.03.006_bib0030","unstructured":"C. NHAENS, https:\/\/www.cdc.gov\/exposurereport\/pdf\/FourthReport_UpdatedTables_Volume1_Jan2019-508.pdf (2019)."},{"issue":"2","key":"10.1016\/j.imlet.2021.03.006_bib0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41370-018-0097-y","article-title":"Exposure to per-fluoroalkyl and polyfluoroalkyl substances leads to immunotoxicity: epidemiological and toxicological evidence","volume":"29","author":"DeWitt","year":"2019","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"issue":"12","key":"10.1016\/j.imlet.2021.03.006_bib0040","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1289\/ehp.1408837","article-title":"Associations of perfluoroalkyl substances (PFAS) with lower birth weight: an evaluation of potential confounding by glomerular filtration rate using a physiologically based pharmacokinetic model (PBPK)","volume":"123","author":"Verner","year":"2015","journal-title":"Environ. Health Perspect."},{"issue":"6","key":"10.1016\/j.imlet.2021.03.006_bib0045","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/10408444.2016.1271972","article-title":"Exposure to PFOA and PFOS and fetal growth: a critical merging of toxicological and epidemiological data","volume":"47","author":"Negri","year":"2017","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.imlet.2021.03.006_bib0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12940-015-0040-9","article-title":"Perfluoroalkyl acids and time to pregnancy revisited: an update from the Danish National Birth Cohort","volume":"14","author":"Bach","year":"2015","journal-title":"Environ. Health"},{"key":"10.1016\/j.imlet.2021.03.006_bib0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.envint.2016.10.015","article-title":"Exposure to perfluoroalkyl substances and thyroid function in pregnant women and children: a systematic review of epidemiologic studies","volume":"99","author":"Ballesteros","year":"2017","journal-title":"Environ. Int."},{"issue":"5194","key":"10.1016\/j.imlet.2021.03.006_bib0060","first-page":"284","article-title":"Scientific Opinion on the risk to human health related to the presence of perfluorooctanesulfonic acid and perfluorooctanoic acid in food","volume":"16","author":"E.C.P.E.P.o.C.i.t.F. Chain)","year":"2018","journal-title":"Efsa J."},{"key":"10.1016\/j.imlet.2021.03.006_bib0065","series-title":"National Toxicology Program Monograph","article-title":"Immunotoxicity associated with exposure to perfluorooctanoic acid or perfluorooctane sulfonate","author":"Monograph","year":"2016"},{"issue":"23","key":"10.1016\/j.imlet.2021.03.006_bib0070","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1080\/15287390802391943","article-title":"Immunomodulatory effects of dietary potassium perfluorooctane sulfonate (PFOS) exposure in adult Sprague-Dawley rats","volume":"71","author":"Lefebvre","year":"2008","journal-title":"J Toxicol Environ Health A"},{"issue":"3","key":"10.1016\/j.imlet.2021.03.006_bib0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tox.2009.06.010","volume":"262","author":"Qazi","year":"2009","journal-title":"Toxicology"},{"issue":"7","key":"10.1016\/j.imlet.2021.03.006_bib0080","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00204-008-0361-3","article-title":"Immunotoxic changes associated with a 7-day oral exposure to perfluorooctanesulfonate (PFOS) in adult male C57BL\/6 mice","volume":"83","author":"Zheng","year":"2009","journal-title":"Arch. Toxicol."},{"issue":"1-3","key":"10.1016\/j.imlet.2021.03.006_bib0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.tox.2009.10.035","volume":"267","author":"Qazi","year":"2010","journal-title":"Toxicology"},{"issue":"10","key":"10.1016\/j.imlet.2021.03.006_bib0090","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00204-011-0661-x","article-title":"Sub-chronic effect of perfluorooctanesulfonate (PFOS) on the balance of type 1 and type 2 cytokine in adult C57BL6 mice","volume":"85","author":"Dong","year":"2011","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.imlet.2021.03.006_bib0095","first-page":"97","article-title":"Effects of perfluorooctane sulfonate (PFOS) exposure on markers of inflammation in female B6C3F1 mice","volume":"46","author":"Mollenhauer","year":"2011","journal-title":"J. Environ. Sci. Health A. Tox. Subst. Environ. Eng."},{"issue":"1","key":"10.1016\/j.imlet.2021.03.006_bib0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/1547691X.2010.537287","article-title":"Type 1 and Type 2 cytokines imbalance in adult male C57BL\/6 mice following a 7-day oral exposure to perfluorooctanesulfonate (PFOS)","volume":"8","author":"Zheng","year":"2011","journal-title":"J. Immunotoxicol."},{"issue":"1","key":"10.1016\/j.imlet.2021.03.006_bib0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/toxsci\/kfn015","article-title":"Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice","volume":"103","author":"Keil","year":"2008","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.imlet.2021.03.006_bib0110","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/toxsci\/kfn059","article-title":"Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate","volume":"104","author":"Peden-Adams","year":"2008","journal-title":"Toxicol. Sci."},{"issue":"1-3","key":"10.1016\/j.imlet.2021.03.006_bib0115","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tox.2009.03.009","volume":"260","author":"Qazi","year":"2009","journal-title":"Toxicology"},{"issue":"11","key":"10.1016\/j.imlet.2021.03.006_bib0120","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.intimp.2010.08.009","article-title":"Dietary exposure to perfluorooctanoate or perfluorooctane sulfonate induces hypertrophy in centrilobular hepatocytes and alters the hepatic immune status in mice","volume":"10","author":"Qazi","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.imlet.2021.03.006_bib0125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cbi.2015.07.015","article-title":"In vivo immunotoxicity of perfluorooctane sulfonate in BALB\/c mice: identification of T-cell receptor and calcium-mediated signaling pathway disruption through gene expression profiling of the spleen","volume":"240","author":"Lv","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"3","key":"10.1016\/j.imlet.2021.03.006_bib0130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1567-5769(00)00030-8","article-title":"Quantitative aspects of stress-induced immunomodulation","volume":"1","author":"Pruett","year":"2001","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.imlet.2021.03.006_bib0135","first-page":"387","article-title":"Evaluation of serum lipid, thyroid, and hepatic clinical chemistries in association with serum perfluorooctanesulfonate (PFOS) in cynomolgus monkeys after oral dosing with potassium PFOS","volume":"156","author":"Chang","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.imlet.2021.03.006_bib0140","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.envres.2006.06.008","article-title":"Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals","volume":"103","author":"Ehresman","year":"2007","journal-title":"Environ. Res."},{"key":"10.1016\/j.imlet.2021.03.006_bib0145","series-title":"Guide for the Care and Use of Laboratory Animals","article-title":"The National Academies Collection: reports funded by National Institutes of Health","author":"C. National Research Council Committee for the Update of the Guide for the, A. Use of Laboratory","year":"2011"},{"issue":"12","key":"10.1016\/j.imlet.2021.03.006_bib0150","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.4049\/jimmunol.167.12.6983","article-title":"The role of antigen in the localization of naive, acutely activated, and memory CD8(+) T cells to the lung during influenza pneumonia","volume":"167","author":"Topham","year":"2001","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2021.03.006_bib0155","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.virol.2005.06.023","article-title":"Antigen-specific and non-specific CD4+ T cell recruitment and proliferation during influenza infection","volume":"340","author":"Chapman","year":"2005","journal-title":"Virology"},{"issue":"132","key":"10.1016\/j.imlet.2021.03.006_bib0160","doi-asserted-by":"crossref","DOI":"10.3791\/57281","article-title":"Isolating lymphocytes from the mouse small intestinal immune system","author":"Qiu","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.imlet.2021.03.006_bib0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4939-0758-8_2","article-title":"Hemagglutination-inhibition assay for influenza virus subtype identification and the detection and quantitation of serum antibodies to influenza virus","volume":"1161","author":"Pedersen","year":"2014","journal-title":"Methods Mol. Biol."},{"issue":"9","key":"10.1016\/j.imlet.2021.03.006_bib0170","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.4049\/jimmunol.168.9.4455","article-title":"Generation of CD8(+) T cell memory in response to low, high, and excessive levels of epitope","volume":"168","author":"Wherry","year":"2002","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2021.03.006_bib0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4049\/jimmunol.170.1.123","article-title":"Detection of low-avidity CD4+ T cells using recombinant artificial APC: following the antiovalbumin immune response","volume":"170","author":"Mallet-Designe","year":"2003","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2021.03.006_bib0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/toxsci\/kfn015","article-title":"Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice","volume":"103","author":"Keil","year":"2008","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.imlet.2021.03.006_bib0185","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/toxsci\/kfn059","article-title":"Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate","volume":"104","author":"Peden-Adams","year":"2008","journal-title":"Toxicol. Sci."},{"issue":"10","key":"10.1016\/j.imlet.2021.03.006_bib0190","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00204-011-0661-x","article-title":"Sub-chronic effect of perfluorooctanesulfonate (PFOS) on the balance of type 1 and type 2 cytokine in adult C57BL6 mice","volume":"85","author":"Dong","year":"2011","journal-title":"Arch. Toxicol."},{"issue":"4","key":"10.1016\/j.imlet.2021.03.006_bib0195","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/10408444.2015.1122573","article-title":"A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humans","volume":"46","author":"Chang","year":"2016","journal-title":"Crit. Rev. Toxicol."},{"issue":"1\u20133","key":"10.1016\/j.imlet.2021.03.006_bib0200","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.tox.2009.10.035","volume":"267","author":"Qazi","year":"2010","journal-title":"Toxicology"},{"issue":"9","key":"10.1016\/j.imlet.2021.03.006_bib0205","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00204-009-0424-0","article-title":"Chronic effects of perfluorooctanesulfonate exposure on immunotoxicity in adult male C57BL\/6 mice","volume":"83","author":"Dong","year":"2009","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.imlet.2021.03.006_bib0210","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-4899-2064-5_15","article-title":"Corticosteroids and the immune response","volume":"245","author":"Claman","year":"1988","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.imlet.2021.03.006_bib0215","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.toxlet.2012.12.001","article-title":"Both sub-acute, moderate-dose and short-term, low-dose dietary exposure of mice to perfluorooctane sulfonate exacerbates concanavalin A-induced hepatitis","volume":"217","author":"Qazi","year":"2013","journal-title":"Toxicol. Lett."},{"issue":"9","key":"10.1016\/j.imlet.2021.03.006_bib0220","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.fct.2012.06.023","article-title":"High-dose dietary exposure of mice to perfluorooctanoate or perfluorooctane sulfonate exerts toxic effects on myeloid and B-lymphoid cells in the bone marrow and these effects are partially dependent on reduced food consumption","volume":"50","author":"Qazi","year":"2012","journal-title":"Food Chem. Toxicol."},{"issue":"9","key":"10.1016\/j.imlet.2021.03.006_bib0225","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00204-009-0424-0","article-title":"Chronic effects of perfluorooctanesulfonate exposure on immunotoxicity in adult male C57BL\/6 mice","volume":"83","author":"Dong","year":"2009","journal-title":"Arch. Toxicol."},{"issue":"7","key":"10.1016\/j.imlet.2021.03.006_bib0230","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00204-008-0361-3","article-title":"Immunotoxic changes associated with a 7-day oral exposure to perfluorooctanesulfonate (PFOS) in adult male C57BL\/6 mice","volume":"83","author":"Zheng","year":"2009","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.imlet.2021.03.006_bib0235","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s13596-013-0105-7","article-title":"Reversal of perfluorooctanesulfonate-induced immunotoxicity by a glucan-resveratrol-vitamin C combination","volume":"13","author":"Vetvicka","year":"2013","journal-title":"Orient. Pharm. Exp. Med."},{"issue":"9","key":"10.1016\/j.imlet.2021.03.006_bib0240","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00204-009-0424-0","article-title":"Chronic effects of perfluorooctanesulfonate exposure on immunotoxicity in adult male C57BL\/6 mice","volume":"83","author":"Dong","year":"2009","journal-title":"Arch. Toxicol."},{"issue":"1-3","key":"10.1016\/j.imlet.2021.03.006_bib0245","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tox.2011.03.014","article-title":"Tissue distribution of (3)(5)S-labelled perfluorooctane sulfonate in adult mice after oral exposure to a low environmentally relevant dose or a high experimental dose","volume":"284","author":"Bogdanska","year":"2011","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.imlet.2021.03.006_bib0250","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1038\/s41598-017-04091-z","article-title":"Perfluorooctane sulfonate affects intestinal immunity against bacterial infection","volume":"7","author":"Suo","year":"2017","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.imlet.2021.03.006_bib0255","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1021\/es060932o","article-title":"Association between perfluorinated compounds and pathological conditions in southern sea otters","volume":"40","author":"Kannan","year":"2006","journal-title":"Environ. Sci. Technol."},{"issue":"6","key":"10.1016\/j.imlet.2021.03.006_bib0260","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.chemosphere.2010.04.060","article-title":"High concentrations of persistent organic pollutants including PCBs, DDT, PBDEs and PFOS in little brown bats with white-nose syndrome in New York, USA","volume":"80","author":"Kannan","year":"2010","journal-title":"Chemosphere"},{"issue":"6","key":"10.1016\/j.imlet.2021.03.006_bib0265","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2131\/jts.34.687","article-title":"Effect of perfluorooctane sulfonate (PFOS) on influenza A virus-induced mortality in female B6C3F1 mice","volume":"34","author":"Guruge","year":"2009","journal-title":"J. Toxicol. Sci."},{"issue":"8","key":"10.1016\/j.imlet.2021.03.006_bib0270","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3390\/v20801530","article-title":"Animal models for influenza virus pathogenesis and transmission","volume":"2","author":"Bouvier","year":"2010","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.imlet.2021.03.006_bib0275","doi-asserted-by":"crossref","first-page":"e4857","DOI":"10.1371\/journal.pone.0004857","article-title":"Host genetic background strongly influences the response to influenza a virus infections","volume":"4","author":"Srivastava","year":"2009","journal-title":"PLoS One"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247821000444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247821000444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:39:14Z","timestamp":1759045154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247821000444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":55,"alternative-id":["S0165247821000444"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2021.03.006","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.01.20.913293","asserted-by":"object"}]},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Perfluorooctanesulfonic acid (PFOS) on immune cell development and function in mice","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2021.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}